Find out if you are eligible for a clinical trial. All studies are carefully designed to safeguard the health of the participant and all studies are approved by the South African Health Products Regulatory Authority (SAHPRA) as well as an independent Ethics Committee prior to implementation.

Clinresco Credentials

Taking pride in our achievements

Clinresco Credentials 1

We’re a IQVIA Partner Site.

Clinresco Centres is a partner site of IQVIA (Previously Quintiles) since February 2009. The goal of this relationship is to improve access to investigative site’s medical staff and patient population, improving access to patients and timely recruitment in clinical trials. A recent analysis of performance done on 21 IQVIA managed studies showed that Clinresco recruited nearly double the number of patients in half the time of an average site involved with studies at IQVIA. IQVIA also assists the site in maintaining a consistently high standard for the conduct of clinical trials.
Clinresco Credentials 2

We’re an ‘INSPIRE’ facility.

In 2013 Clinresco was identified by Pfizer, the largest pharmaceutical company in the world, as a site that meets the exacting standards that the company demands to join a worldwide network of 150 INSPIRE sites, which must be both highly productive and effective.

INSPIRE – Investigator Networks, Site Partnerships and Infrastructure for Research Excellence

INSPIRE sites have early access to Pfizer’s portfolio data and advanced information regarding the clinical trials to be sponsored by Pfizer. Clinresco is proud to be part of this global network of clinical research institutions.

Clinresco Credentials 3

WHO Auditor Training

On behalf of the World Health Organisation (WHO) the South African Health Products Regulatory Authority (SAHPRA), from time to time, trains GCP auditors from African States.  In 2013, due to our exceptional performance in conducting clinical trials, Clinresco was selected to host a one-day mock inspection as part of the training of 14 clinical trial inspector trainees.

The successful training, lead by a member of the regulatory authority (SAHPRA), was done on a paper based clinical report form (CRF) study with input from Clinresco personnel. The required physical facilities and systems for conducting approved clinical trials was explained and viewed in detail.

Past clinical studies undertaken

Clinresco has performed clinical studies in the following therapeutic areas:
  • Ankylosing spondylitis
  • Atrial fibrillation
  • Cardiovascular diseases (including heart attacks and strokes)
  • Chronic heart failure
  • Chronic obstructive pulmonary disease
  • Diabetes Mellitus (Type II)
  • Hyperlipidaemia
  • Hypertension
  • Gout
  • Infections
  • Influenza
  • Osteoarthritis
  • Osteoporosis
  • Pain management
  • Prostate cancer
  • Psoriatic arthritis
  • Radiation dermatitis
  • Rheumatoid arthritis
  • Thrombotic events


Submit your details with the form below. Your information is kept confidential.

15 + 5 =